J Haxby Abbott1, John S Schmitt2. 1. Centre for Musculoskeletal Outcomes Research, Orthopaedic Surgery Section, Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Great King Street, Dunedin 9054, New Zealand. Electronic address: haxby.abbott@mac.com. 2. Doctor of Physical Therapy Program, Henrietta Schmoll School of Health, St. Catherine University, 601 25th Avenue South, Minneapolis, MN 55454, USA.
Abstract
OBJECTIVES: To examine the validity of the Patient-Specific Functional Scale (PSFS) for the assessment of group-level change and between-group discrimination in group-level data. STUDY DESIGN AND SETTING: We collected complete baseline and follow-up PSFS data in 1,181 consecutive patients reporting to physical therapy with a musculoskeletal disorder. Physical function was assessed at the baseline and final physical therapy visits using the PSFS and four region-specific patient-reported outcome (PRO) measures: The Neck Disability Index, Oswestry Disability Index, Upper Extremity Functional Index, and Lower Extremity Functional Scale. Global Rating of Change (GROC) was assessed at discharge. We assessed data distribution and floor and ceiling effects. Correlation and linear regression analyses assessed concurrent, convergent, and discriminant validities of PSFS baseline, final, and change scores across the cohort. One-way ANOVA was used to test for differences in PSFS scores among strata defined by region-specific PRO score and GROC. Cohen's d was used to assess responsiveness. RESULTS: Results supported the concurrent, convergent, and discriminant validities (all P < 0.001), scale consistency (P < 0.001 omnibus, P < 0.05 post hoc tests), distribution, and responsiveness of the PSFS for both between-group discrimination and assessment of change over time in group-level data. The PSFS performed better than comparison PRO measures in most comparisons. CONCLUSION: These results indicate that the PSFS is an appropriate measure for statistical comparisons in clinical research.
OBJECTIVES: To examine the validity of the Patient-Specific Functional Scale (PSFS) for the assessment of group-level change and between-group discrimination in group-level data. STUDY DESIGN AND SETTING: We collected complete baseline and follow-up PSFS data in 1,181 consecutive patients reporting to physical therapy with a musculoskeletal disorder. Physical function was assessed at the baseline and final physical therapy visits using the PSFS and four region-specific patient-reported outcome (PRO) measures: The Neck Disability Index, Oswestry Disability Index, Upper Extremity Functional Index, and Lower Extremity Functional Scale. Global Rating of Change (GROC) was assessed at discharge. We assessed data distribution and floor and ceiling effects. Correlation and linear regression analyses assessed concurrent, convergent, and discriminant validities of PSFS baseline, final, and change scores across the cohort. One-way ANOVA was used to test for differences in PSFS scores among strata defined by region-specific PRO score and GROC. Cohen's d was used to assess responsiveness. RESULTS: Results supported the concurrent, convergent, and discriminant validities (all P < 0.001), scale consistency (P < 0.001 omnibus, P < 0.05 post hoc tests), distribution, and responsiveness of the PSFS for both between-group discrimination and assessment of change over time in group-level data. The PSFS performed better than comparison PRO measures in most comparisons. CONCLUSION: These results indicate that the PSFS is an appropriate measure for statistical comparisons in clinical research.
Authors: A F Mannion; A Vila-Casademunt; M Domingo-Sàbat; S Wunderlin; F Pellisé; J Bago; E Acaroglu; A Alanay; F S Pérez-Grueso; I Obeid; F S Kleinstück Journal: Eur Spine J Date: 2015-10-30 Impact factor: 3.134
Authors: Goris Nazari; Pavlos Bobos; Steve Lu; Stephanie Reischl; Pedro H Almeida; Joy C MacDermid Journal: Physiother Can Date: 2021-06-07 Impact factor: 1.037
Authors: Charles J Gerardo; Joao R N Vissoci; Leonardo P de Oliveira; Victoria E Anderson; Eugenia Quackenbush; Brandon Lewis; S Rutherfoord Rose; Spencer Greene; Eric A Toschlog; Nathan P Charlton; Michael E Mullins; Richard Schwartz; David Denning; Kapil Sharma; Kurt Kleinschmidt; Sean P Bush; Nicklaus P Brandehoff; Eric J Lavonas Journal: PLoS One Date: 2019-03-05 Impact factor: 3.240
Authors: Anupa Pathak; Saurab Sharma; Allen W Heinemann; Paul W Stratford; Daniel Cury Ribeiro; J Haxby Abbott Journal: Qual Life Res Date: 2020-09-23 Impact factor: 3.440